Cargando…
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
BACKGROUND: Increased usage of genomic risk assessment assays suggests increased reliance on data provided by these assays to guide therapy decisions. The current study aimed to assess the change in treatment decision and physician confidence based on the 70-gene risk of recurrence signature (70-GS,...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995096/ https://www.ncbi.nlm.nih.gov/pubmed/32005181 http://dx.doi.org/10.1186/s12885-020-6534-z |